CFIC
NXTM

City Financial Investment Company’s NxStage Medical Inc. NXTM Stock Holding History

City Financial Investment Company’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-289,860
Closed -$8.09M – 184
2018
Q2 		$8.09M Sell
289,860
-296,096
-51% -$7.94M 0.41% 42
2018
Q1 		$14.6M Sell
585,956
-168,330
-22% -$4.09M 0.98% 16
2017
Q4 		$18.3M Buy
754,286
+54,786
+8% +$1.44M 2.2% 17
2017
Q3 		$19.3M Buy
+699,500
New +$18.7M 1.22% 26

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.71% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WIC
Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return

City Financial Investment Company's NXTM Position: Q3 2018 in Review

City Financial Investment Company sold out of NxStage Medical Inc. (NXTM) in Q3 2018, closing a stake of 289,860 shares — an estimated $8.09M sold.

City Financial Investment Company first reported a position in NXTM in Q3 2017 and held it in 4 quarters. The position peaked at $19.3M in Q3 2017. 175 funds tracked by Wall St. Rank hold NXTM as of Q3 2018.

  • City Financial Investment Company reported no remaining NxStage Medical Inc. position as of Q3 2018 after selling out during the quarter.
  • City Financial Investment Company sold 289,860 NxStage Medical Inc. shares in Q3 2018, an estimated $8.09M.
  • City Financial Investment Company first reported a position in NxStage Medical Inc. in Q3 2017 and held it in 4 quarters.
  • City Financial Investment Company's NxStage Medical Inc. position peaked at $19.3M in Q3 2017.
  • 175 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2018.

Based on City Financial Investment Company's 13F filing for Q3 2018, filed 9 Nov 2018.